Wilmington, MA December 15, 2015—Interventional pioneer Micro Medical Solutions announces the closing on its latest round of funding, bringing total raised from equity financings to date to approximately $3.6 million. The funding will be used for further development and clinical trials for its Below the Knee (BTK) stent delivery platform. CEO Gregory Sullivan commented that “this equity financing allows us to bolster our research and development, quality assurance testing, and regulatory approval processes for our first-in-class technology as we move toward 510K and CE Mark approval for several of our innovative minimally invasive products in 2016.” Micro Medical Solutions plans for the launch of its Micro Vascular Integrated Platform (mVIP) in 2017 for the treatment of peripheral artery disease (PAD)/critical limb ischemia (CLI) lesions BTK, and prevention of amputations due to CLI.

CONTACT: Peg Thornton, Director of Corporate and Market Development, Micro Medical Solutions 732-616-9123